Skip to main content

Advertisement

SpringerLink
Log in

Neurogenic lower urinary tract dysfunction in multiple sclerosis, neuromyelitis optica, and related disorders

  • Review
  • Published:
Clinical Autonomic Research Aims and scope Submit manuscript

Abstract

Purpose

Multiple sclerosis (MS), neuromyelitis optica (NMO), and related disorders are major immune-mediated central nervous system diseases affecting the spinal cord. We reviewed the occurrence of neurogenic lower urinary tract dysfunction (NLUTD) in these categories of diseases.

Methods

We systematically reviewed the literature regarding bladder dysfunction in MS, NMO spectrum disorder (NMOSD), and related disorders (acute disseminated encephalomyelitis, acute immune-mediated myelopathy, and meningitis-retention syndrome).

Results

The literature, although somewhat limited for diseases other than MS, suggests that bladder dysfunction is not uncommon in these diseases, presumably reflecting lesions in the spinal descending and ascending pathways. The pattern of bladder dysfunction is a combination of overactive bladder and large post-void residuals/urinary retention. Post-void residual is measured by portable ultrasound devices.

Conclusions

Because of the complexity of bladder behavior, careful consideration of bladder management is necessary in MS, NMO, and related disorders: e.g., antimuscarinics, etc., for overactive bladder and clean, intermittent self-catheterization for urinary retention. These management practices should help improve patients’ quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

modified from Refs. 36, 51)

Fig. 4

Similar content being viewed by others

References

  1. Abboud H, Hill E, Siddiqui J, Serra A, Walter B (2017) Neuromodulation in multiple sclerosis. Mult Scler 23:1663–1676

    Article  PubMed  Google Scholar 

  2. Adamec I, Habek M (2013) Autonomic dysfunction in multiple sclerosis. Clin Neurol Neurosurg 115(Suppl 1):S73–S78

    Article  PubMed  Google Scholar 

  3. Altuntas CZ, Daneshgari F, Liu G, Fabiyi A, Kavran M, Johnson JM, Gulen MF, Jaini R, Li X, Frenkl TL, Tuohy VK (2008) Bladder dysfunction in mice with experimental autoimmune encephalomyelitis. J Neuroimmunol 203:58–63

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Amarenco G, Raibaut P, Hubeaux K, Jousse M, Sheikh Ismaël S, Lapeyre E (2013) Autonomic nervous system alteration in multiple sclerosis patients with urinary symptoms. Clinical, urodynamic and cardiovascular study. Prog Urol 23:1505–1510

    Article  CAS  PubMed  Google Scholar 

  5. Basoulis D, Mylon M, Toskas P, Tsilingiris D, Fytili C (2015) Meningitis-retention syndrome. Int Neurourol J 19:207–209

    Article  PubMed  PubMed Central  Google Scholar 

  6. Bradl M, Reindl M, Lassmann H (2018) Mechanisms for lesion localization in neuromyelitis optica spectrum disorders. Curr Opin Neurol 31:325–333

    PubMed  PubMed Central  Google Scholar 

  7. Burla MJ, Benjamin J (2016) Pediatric urinary retention in the emergency department: a concerning symptom with etiology outside the bladder. J Emerg Med 50:e53–e56

    Article  PubMed  Google Scholar 

  8. Canbaz Kabay S, Kabay S, Mestan E, Cetiner M, Ayas S, Sevim M, Ozden H, Karaman HO (2017) Long term sustained therapeutic effects of percutaneous posterior tibial nerve stimulation treatment of neurogenic overactive bladder in multiple sclerosis patients: 12 months results. Neurourol Urodyn 36:104–110

    Article  PubMed  Google Scholar 

  9. Canon S, Shera A, Phan NM, Lapicz L, Scheidweiler T, Batchelor L, Swearingen C (2015) Autonomic dysreflexia during urodynamics in children and adolescents with spinal cord injury or severe neurologic disease. J Pediatr Urol 11:32 e1–32 e4

    Article  Google Scholar 

  10. Cartier RL, Hansen BF (2014) Meningitis-retention syndrome. Rep One Case Rev Med Chile 142:1607–1611

    Article  Google Scholar 

  11. Castel-Lacanal E, Gamé X, Clanet M, Gasq D, De Boissezon X, Guillotreau J, Bourg V, Viala F, Rischmann P, Marque P (2015) Urinary complications and risk factors in symptomatic multiple sclerosis patients. Study of a cohort of 328 patients. Neurourol Urodyn 34:32–36

    Article  PubMed  Google Scholar 

  12. Charil A, Zijdenbos AP, Taylor J, Boelman C, Worsley KJ, Evans AC, Dagher A (2003) Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: application to 452 patient data sets. Neuroimage 19:532–544

    Article  PubMed  Google Scholar 

  13. de Carvalho FL, Gomes CM, Apostolos-Pereira SL, Bessa J Jr, Pinheiro M, Marchiori PE, Bruschini H, Srougi M, Callegaro D (2016) Voiding dysfunction in patients with neuromyelitis optica spectrum disorders. Neurourol Urodyn 35:39–43

    Article  PubMed  Google Scholar 

  14. De Ridder D, Der Van, Aa F, Debruyne J, D’hooghe MB, Dubois B, Guillaume D, Heerings M, Ilsbroukx S, Medaer R, Nagels G, Seeldrayers P, Van Landegem W, Willekens B, Zicot AF (2013) Consensus guidelines on the neurologist’s role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis. Clin Neurol Neurosurg 115:2033–2040

    Article  PubMed  Google Scholar 

  15. De Santis G, Zenzola A, Carbone A, Ciardo G (2015) Neurogenic sphincters dysfunction as unusual clinical picture of ADEM. Acta Neurol Belg 115:787–788

    Article  PubMed  Google Scholar 

  16. de Sèze M, Ruffion A, Denys P, Joseph PA, Perrouin-Verbe B, GENULF (2007) The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines. Mult Scler 13:915–928

    Article  PubMed  Google Scholar 

  17. Dimitrijevic N, Bogicevic D, Dimitrijevic A, Nikolic D (2012) Early presentation of neuromyelitis optica. Indian Pediatr 49:924–925

    Article  PubMed  Google Scholar 

  18. Dos Passos GR, Oliveira LM, da Costa BK, Apostolos-Pereira SL, Callegaro D, Fujihara K, Sato DK (2018) MOG-IgG-associated optic neuritis, encephalitis, and myelitis: lessons learned from neuromyelitis optica spectrum disorder. Front Neurol 9:217

    Article  PubMed  PubMed Central  Google Scholar 

  19. Flanagan EP (2016) Autoimmune myelopathies. Handb Clin Neurol 133:327–351

    Article  PubMed  Google Scholar 

  20. Fowler CJ (2010) The effectiveness of bladder rehabilitation in multiple sclerosis. J Neurol Neurosurg Psychiatry 81:944

    Article  PubMed  Google Scholar 

  21. Fowler CJ, Panicker JN, Drake M, Harris C, Harrison SC, Kirby M, Lucas M, Macleod N, Mangnall J, North A, Porter B, Reid S, Russell N, Watkiss K, Wells M (2009) A UK consensus on th management of the bladder in multiple sclerosis. J Neurol Neurosurg Psychiatry 80:470–477

    CAS  PubMed  Google Scholar 

  22. Franken J, Gevaert T, Uvin P, Wauterickx K, Boeve AC, Rietjens R, Boudes M, Hendriks JJ, Hellings N, Voets T, De Ridder D (2016) Urodynamic changes in mice with experimental autoimmune encephalomyelitis correlate with neurological impairment. Neurourol Urodyn 35:450–456

    Article  CAS  PubMed  Google Scholar 

  23. Fujiki F, Tsuboi Y, Hori T, Yamada T (2008) Aseptic meningitis as initial presentation of acute disseminated encephalomyelitis. J Neurol Sci 272(1–2):129–131

    Article  PubMed  Google Scholar 

  24. Furlana JC (2018) Autonomic dysreflexia following acute myelitis due to neuromyelitis optica. Mult Scler Relat Disord 23:1–3

    Article  Google Scholar 

  25. Gajewski JB, Schurch B, Hamid R, Averbeck M, Sakakibara R, Agrò EF, Dickinson T, Payne CK, Drake MJ, Haylen BT (2018) An International Continence Society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD). Neurourol Urodyn 37:1152–1161

    Article  PubMed  Google Scholar 

  26. Ghezzi A, Carone R, Del Popolo G, Amato MP, Bertolotto A, Comola M, Del Carro U, Di Benedetto P, Giannantoni A, Lopes de Carvalho ML, Montanari E, Patti F, Protti A, Rasia S, Salonia A, Scandellari C, Sperli F, Spinelli M, Solaro C, Uccelli A, Zaffaroni M, Zipoli V, Multiple Sclerosis Study Group, Italian Society of Neurology (2011) Recommendations for the management of urinary disorders in multiple sclerosis: a consensus of the Italian Multiple Sclerosis Study Group. Neurol Sci 32:1223–1231

    Article  CAS  PubMed  Google Scholar 

  27. Gliga LA, Lavelle RS, Christie AL, Coskun B, Greenberg BM, Carmel ME, Lemack GE (2017) Urodynamics findings in transverse myelitis patients with lower urinary tract symptoms: results from a tertiary referral urodynamic center. Neurourol Urodyn 36:360–363

    Article  PubMed  Google Scholar 

  28. Gupta A, Kumar SN, Taly AB (2017) Urodynamic profile in acute transverse myelitis patients: its correlation with neurological outcome. J Neurosci Rural Pract 8:44–48

    Article  PubMed  PubMed Central  Google Scholar 

  29. Hiraga A, Kuwabara S (2018) Meningitis-retention syndrome: clinical features, frequency and prognosis. J Neurol Sci 390:261–264

    Article  PubMed  Google Scholar 

  30. Hiraga A, Sakakibara R, Mori M, Suzuki A, Hattori T (2005) Bilateral lesion in the lateral columns and complete urinary retention: association with the spinal cord descending pathway for micturition. Neurourol Urodyn 24:398–399

    Article  PubMed  Google Scholar 

  31. Hiraga A, Sakakibara R, Mori M, Yamanaka Y, Ito S, Hattori T (2006) Urinary retention can be the sole initial manifestation of acute myelitis. J Neurol Sci 251:110–112

    Article  CAS  PubMed  Google Scholar 

  32. Hiraga A, Takatsuna Y, Sakakibara R, Kamitsukasa I, Minamide M, Kuwabara S (2014) Vogt–Koyanagi–Harada disease with meningitis-retention syndrome and increased CSF adenosine deaminase levels. Clin Neurol Neurosurg 127:42–43

    Article  PubMed  Google Scholar 

  33. Hollingsworth JM, Rogers MA, Krein SL, Hickner A, Kuhn L, Cheng A, Chang R, Saint S (2013) Determining the noninfectious complications of indwelling urethral catheters: a systematic review and meta-analysis. Ann Intern Med 159:401–410

    Article  PubMed  Google Scholar 

  34. Ishii G, Hata K, Aoki S, Suzuki M, Kimura T, Egawa S (2016) Meningitis-retention syndrome. Case Rep Urol Case Rep 6:42–44

    PubMed  Google Scholar 

  35. Jayakrishnan MP, Krishnakumar P, Gauthamen R, Sabitha S, Devarajan E (2012) Autonomic dysreflexia in acute disseminated encephalomyelitis. Pediatr Neurol 47:309–311

    Article  PubMed  Google Scholar 

  36. Jin Z, Ding Y, Xue R, Jia Z, Huang Z, Ding Y, Gu C, Yang J (2017) Involvement of interstitial cells of Cajal in bladder dysfunction in mice with experimental autoimmune encephalomyelitis. Int Urol Nephrol 49:1353–1359

    Article  CAS  PubMed  Google Scholar 

  37. Kanesaka T, Sakakibara R, Ito S, Ito T, Odaka T, Yamaguchi T, Uchiyama T, Liu Z, Yamamoto T, Hattori T (2006) Intestinal pseudo-obstruction in acute myelitis. Intern Med 45:35–36

    Article  PubMed  Google Scholar 

  38. Kennedy F, Elsberg CA, Lambert CI (1913) A peculiar undescribed disease of the nerves of the cauda equina. Am J Med Sci 147:645–667

    Article  Google Scholar 

  39. Kim T, Whang J, Lee S, Choi J, Park S, Lee J (2010) Acute urinary retention due to aseptic meningitis: meningitis-retention syndrome. Int Neurourol J 14:122–124

    Article  PubMed  PubMed Central  Google Scholar 

  40. Kim SM, Waters P, Woodhall M, Yang JW, Yang H, Kim JE, Sung JJ, Park KS, Lee KW (2014) Characterization of the spectrum of Korean inflammatory demyelinating diseases according to the diagnostic criteria and AQP4-Ab status. BMC Neurol 14:93

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Koutsis G, Evangelopoulos ME, Sfagos C, Markianos M (2016) Neurochemical and neuroendocrine correlates of overactive bladder at first demyelinating episode. Neurourol Urodyn 35:955–958

    Article  CAS  PubMed  Google Scholar 

  42. Krishna A, Devulapally P, Ghobrial I (2012) Meningitis retention syndrome. J Community Hosp Intern Med Perspect 2:15761. https://doi.org/10.3402/jchimp.v2i1.15761

    Article  Google Scholar 

  43. Legrand G, Rouprêt M, Comperat E, Even-Schneider A, Denys P, Chartier-Kastler E (2011) Functional outcomes after management of end-stage neurological bladder dysfunction with ileal conduit in a multiple sclerosis population: a monocentric experience. Urology 78:937–941

    Article  PubMed  Google Scholar 

  44. Lifson JD, Oyasu R, Dreyer N, Carone FA, Williams RM (1983) Acute hemorrhagic obstructive uropathy as a complication of experimental autoimmune encephalomyelitis. Arch Pathol Lab Med 107:600–602

    CAS  PubMed  Google Scholar 

  45. Mankongpaisarnrung C, Laengvejkal P, Argueta E, Limsuwat C, Sutamtewagul G, Nugent K (2013) Meningitis-retention syndrome as a presentation of West Nile virus meningitis. Case Rep Med 2013:984345. https://doi.org/10.1155/2013/984345

    Article  PubMed  PubMed Central  Google Scholar 

  46. Mutch K, Zhao S, Hamid S, Methley A, Elsone L, Singh G, Young C, Emmanuel A, Panicker J, Jacob A (2015) Bladder and bowel dysfunction affect quality of life. A cross sectional study of 60 patients with aquaporin-4 antibody positive neuromyelitis optica spectrum disorder. Mult Scler Relat Disord 4:614–618

    Article  PubMed  Google Scholar 

  47. Nielsen S, Germanos R, Weier M, Pollard J, Degenhardt L, Hall W, Buckley N, Farrell M (2018) The use of cannabis and cannabinoids in treating symptoms of multiple sclerosis: a systematic review of reviews. Curr Neurol Neurosci Rep 18(2):8

    Article  CAS  PubMed  Google Scholar 

  48. Ochi H, Fujihara K (2016) Demyelinating diseases in Asia. Curr Opin Neurol 29:222–228

    Article  CAS  PubMed  Google Scholar 

  49. Panicker JN, Fowler CJ (2015) Lower urinary tract dysfunction in patients with multiple sclerosis. Handb Clin Neurol 130:371–381

    Article  PubMed  Google Scholar 

  50. Panicker JN, Nagaraja D, Kovoor JM, Nair KP, Subbakrishna DK (2009) Lower urinary tract dysfunction in acute disseminated encephalomyelitis. Mult Scler 15:1118–1122

    Article  CAS  PubMed  Google Scholar 

  51. Phé V, Chartier-Kastler E, Panicker JN (2016) Management of neurogenic bladder in patients with multiple sclerosis. Nat Rev Urol 13:275–288

    Article  CAS  Google Scholar 

  52. Podnar S, Vodušek DB (2014) Place of perineal electrophysiologic testing in multiple sclerosis patients. Ann Phys Rehabil Med 57:288–296

    Article  CAS  PubMed  Google Scholar 

  53. Pohl D, Alper G, Van Haren K, Kornberg AJ, Lucchinetti CF, Tenembaum S, Belman AL (2016) Acute disseminated encephalomyelitis: updates on an inflammatory CNS syndrome. Neurology 87(9 Suppl 2):S38–S45

    Article  PubMed  Google Scholar 

  54. Pozzilli C, Grasso MG, Bastianello S, Anzini A, Salvetti M, Bozzao L, Von Heland M, Fieschi C (1992) Structural brain correlates of neurologic abnormalities in multiple sclerosis. Eur Neurol 32:228–230

    Article  CAS  PubMed  Google Scholar 

  55. Sakakibara R, Hattori T, Yasuda K, Yamanishi T (1996) Micturitional disturbance in acute disseminated encephalomyelitis (ADEM). J Auton Nerv Syst 60:200–205

    Article  CAS  PubMed  Google Scholar 

  56. Sakakibara R, Hattori T, Yasuda K, Yamanishi T (1996) Micturition disturbance in acute transverse myelitis. Spinal Cord 34:481–485

    Article  CAS  PubMed  Google Scholar 

  57. Sakakibara R, Mori M, Fukutake T, Kita K, Hattori T (1997) Orthostatic hypotension in a case with multiple sclerosis. Clin Auton Res 7:163–165

    Article  CAS  PubMed  Google Scholar 

  58. Sakakibara R, Uchiyama T, Liu Z, Yamamoto T, Ito T, Uzawa A et al (2005) Meningitis-retention syndrome; an unrecognized clinical condition. J Neurol 252:1495–1499

    Article  PubMed  Google Scholar 

  59. Sakakibara R, Kishi M, Tsuyusaki Y, Tateno A, Tateno F, Uchiyama T, Yamamoto T, Yamanishi T, Yano M (2013) “Meningitis-retention syndrome”: a review. Neurourol Urodyn 32:19–23

    Article  PubMed  Google Scholar 

  60. Sakakibara R, Ito T, Yamamoto T, Uchiyama T, Yamanishi T, Kishi M, Tsuyusaki Y, Tateno F, Katsuragawa S, Kuroki N (2013) Depression, anxiety and the bladder. Low Urin Tract Symptoms 5:109–120

    Article  PubMed  Google Scholar 

  61. Schurch B, Carda S (2014) Onabotulinumtoxin A and multiple sclerosis. Ann Phys Rehabil Med 57:302–314

    Article  CAS  PubMed  Google Scholar 

  62. Sheremata W, Tornes L (2013) Multiple sclerosis and the spinal cord. Neurol Clin 31:55–77

    Article  PubMed  Google Scholar 

  63. Tamam Y, Özdemir HH, Gedik A, Tamam C, Nazlıkul H (2017) Efficacy of peripheral lidocaine application (neural therapy) in the treatment of neurogenic detrusor overactivity in multiple sclerosis patients. Neurourol Urodyn 36:1832–1838

    Article  CAS  PubMed  Google Scholar 

  64. Tateno F, Sakakibara R, Sugiyama M, Takahashi O, Kishi M, Ogawa E et al (2011) Meningitis-retention syndrome: first case of urodynamic follow-up. Intern Med 50:1329–1332

    Article  PubMed  Google Scholar 

  65. Ukkonen M, Elovaara I, Dastidar P, Tammela TL (2004) Urodynamic findings in primary progressive multiple sclerosis are associated with increased volumes of plaques and atrophy in the central nervous system. Acta Neurol Scand 109:100–105

    Article  CAS  PubMed  Google Scholar 

  66. Vignes JR, Deloire MS, Petry KG, Nagy F (2007) Characterization and restoration of altered inhibitory and excitatory control of micturition reflex in experimental autoimmune encephalomyelitis in rats. J Physiol 578(Pt 2):439–450

    Article  CAS  PubMed  Google Scholar 

  67. Vignes JR, Deloire M, Petry K (2009) Animal models of sacral neuromodulation for detrusor overactivity. Neurourol Urodyn 28:8–12

    Article  PubMed  Google Scholar 

  68. Weissbart SJ, Pechersky D, Malykhina A, Bavaria T, Parrillo L, Arya LA, Bilello M, Wein AJ, Smith AL (2017) The impact of pontine disease on lower urinary tract symptoms in patients with multiple sclerosis. Neurourol Urodyn 36:453–456

    Article  PubMed  Google Scholar 

  69. Wingerchuk DM (2018) Immune-mediated myelopathies. Continuum Minneap Minn 24(2 Spinal Cord Disorders):497–522

    PubMed  Google Scholar 

  70. Wingerchuk DM, Weinshenker BG (2014) Neuromyelitis optica (Devic’s syndrome). Handb Clin Neurol 122:581–599

    Article  PubMed  Google Scholar 

  71. Yamamoto T, Masahiro Mori M, Uzawa A, Uchiyama T, Sakakibara R, Yanagisawa M, Kuwabara S (2015) Urinary symptoms and neurological disabilities are differentially correlated between multiple sclerosis and neuromyelitis optica. Clin Exp Neuroimmunol 7(1):52–58. https://doi.org/10.1111/cen3.12279

    Article  CAS  Google Scholar 

  72. Zachariou A, Filiponi M, Baltogiannis D, Giannakis J, Dimitriadis F, Tsounapi P, Takenaka A, Sofikitis N (2017) Effective treatment of neurogenic detrusor overactivity in multiple sclerosis patients using desmopressin and mirabegron. Can J Urol 24:9107–9113

    PubMed  Google Scholar 

  73. Zurawski J, Stankiewicz J (2018) Multiple sclerosis re-examined: essential and emerging clinical concepts. Am J Med 131:464–472

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurology, Internal Medicine, Sakura Medical Center, Toho University, 564-1 Shimoshizu, Sakura, 285-8741, Japan

    Ryuji Sakakibara

Authors
  1. Ryuji Sakakibara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ryuji Sakakibara.

Ethics declarations

Conflict of interest

We have no conflict of interest.

Ethical approval

This article conforms to the ethical standards of the declaration of Helsinki.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sakakibara, R. Neurogenic lower urinary tract dysfunction in multiple sclerosis, neuromyelitis optica, and related disorders. Clin Auton Res 29, 313–320 (2019). https://doi.org/10.1007/s10286-018-0551-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10286-018-0551-x

Keywords

Search

Navigation